Novanta
NOVTPrivate Company
Total funding raised: $15M
Overview
Novanta is a publicly traded, revenue-generating enabler of high-precision technology, serving as a critical B2B partner to medical device and advanced manufacturing OEMs. The company's strategy centers on deep, system-level engineering across its synergistic technology platforms—Photonics, Vision, and Precision Motion—to deliver integrated solutions for complex applications. Through organic innovation and strategic acquisitions, Novanta capitalizes on long-term secular trends in surgical robotics, automation, and precision medicine, aiming for sustainable growth and market leadership.
Technology Platform
A synergistic portfolio of three core technology domains—Photonics, Vision, and Precision Motion—engineered with a system-level mindset to provide integrated components and subsystems for medical and advanced industrial OEM applications.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Novanta competes against large conglomerates (e.g., Danaher, Siemens) and niche specialists (e.g., Coherent, Cognex). Its primary differentiator is its system-level engineering expertise across photonics, vision, and precision motion, allowing it to provide integrated solutions rather than standalone components.